Guam Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on November 17, 2025

November 17, 2025

Ruanyun Edai Technology Announces Commercial Release of Cogni AI – Providing Multimodal Visual Understanding and Recognition

GlobeNewswire

November 17, 2025

EdgeMode Executes Definitive Agreement with Blackberry AIF to Develop 1.5GW+ Tier 3 AI Data Center Portfolio in Spain

GlobeNewswire

November 17, 2025

ODYSIGHT.AI APPOINTS EILAM SAGI AS CHIEF BUSINESS OFFICER (CBO)

GlobeNewswire

November 17, 2025

Scope Technologies Corp. Achieves CyberSecure Canada Level 2 Certification, Advancing Its Leadership in Quantum-Resilient Security and Compliance

GlobeNewswire

November 17, 2025

Four Points Technology Achieves CMMC 2.0 Level 2 Certification

GlobeNewswire

November 17, 2025

Ashvattha Therapeutics to Showcase Topline Phase 2 Data and Recent FDA Alignment at Upcoming Investor and Ophthalmology Meetings

GlobeNewswire

November 17, 2025

Rackspace Technology Appoints Lata Varghese and Phani Kishore Burre to Senior Leadership Roles Driving Cloud and AI Transformation

GlobeNewswire

November 17, 2025

Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD

GlobeNewswire

November 17, 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 17, 2025

Hummink raises $20 million to bring micronic precision printing to advanced manufacturing

GlobeNewswire

November 17, 2025

Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease

GlobeNewswire

November 17, 2025

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

GlobeNewswire

November 17, 2025

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

GlobeNewswire

November 17, 2025

T-knife Therapeutics Files Clinical Trial Application for Phase 1 ATLAS Trial for TK-6302, a Supercharged PRAME-targeted T Cell Receptor Therapy

GlobeNewswire

November 17, 2025

NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts

GlobeNewswire

November 17, 2025

Porosome Therapeutics Publishes Preclinical Findings Demonstrating Restoration of Neuronal Secretion and Reversal of Alzheimer’s Disease Pathology Following Porosome Reconstitution Therapy

GlobeNewswire

November 17, 2025

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

GlobeNewswire

November 17, 2025

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the 26th Annual Meeting of the Society of Urologic Oncology

GlobeNewswire

November 17, 2025

Mavenir to Deliver Corporate Update and AI Vision at Annual Global Analyst Event

GlobeNewswire

November 17, 2025

Datavault AI Signs Multi-Million Dollar Tokenization Services Agreement With Triton Geothermal to Provide Significant Revenue Opportunities

GlobeNewswire